Why did 4596.T stock jump pre-market on Feb 03 2026?

The jump was driven by heavy volume (28,431,100 shares) and a technical breakout above the 50- and 200-day averages. No confirmed company press release was posted, so traders may be positioning ahead of earnings and clinical milestones

What is Meyka AI’s short-term forecast for 4596.T stock?

Meyka AI's forecast model projects a monthly price of **JPY 98.52**, which implies an approximate **-22.4%** downside from the current **JPY 127.00**. Forecasts are model-based projections and not guarantees

Should I buy Kubota Pharmaceutical (4596.T) after the rally?

Given negative EPS and high volatility, Meyka AI assigns a Grade B and suggests HOLD. Traders can trade momentum with tight stops; long-term investors should wait for clinical or earnings confirmation

What are the main risks for 4596.T stock?

Major risks include negative profitability (EPS -19.06), binary clinical outcomes tied to the pipeline, high valuation metrics relative to revenue, and short-term volatility driven by low institutional liquidity

JP Stocks

4596.T stock up 30.93% pre-market Feb 03 2026: Kubota Pharmaceutical (JPX) outlook

ByDanny Kontos February 3, 2026February 3, 2026

4596.T stock opened the pre-market session on Feb 03 2026 with a sharp gain of 30.93%, rising to JPY 127.00 on extremely high volume. The move came with 28,431,100 shares traded versus an average of 2,719,146, a relVolume of 10.46, signalling an outsized intraday interest. We see the surge as a fast technical breakout above the 50-day average (JPY 51.38) and 200-day average (JPY 53.66). This article breaks down fundamentals, technicals, Meyka AI grade and short-term forecasts for Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) on the JPX